<DOC>
	<DOCNO>NCT01408056</DOCNO>
	<brief_summary>The purpose study determine whether Timolol 0.5 % Gel Forming Solution safe effective promoting wound heal infantile ulcerate hemangioma compare standard conservative management topical antibiotic .</brief_summary>
	<brief_title>Timolol Option Ulcerated Hemangiomas ( TOUCH Trial )</brief_title>
	<detailed_description>Ulceration common complication associate infantile hemangioma . Ulceration delay wound heal place patient risk infection , bleeding , pain permanent scarring . Currently , care ulcerated hemangioma extremely difficult patient often subject multiple treatment modality . In past two year , lead advance treatment hemangioma use non-selective , oral beta-blocker propranolol arrest growth promote involution hemangioma . Recent literature also suggest beta-blockers may role help ulcerated wound re-epithelialize . The use topical non-selective beta-blocker isolate ulcerated hemangioma may promote early healing reduce number complication associate ulceration . Investigation need explore safety tolerability apply topical beta-blocker ulcerated hemangioma whether topical beta-blockade may efficacious conservative care topical antibiotic . In study , infant randomize either receive topical antibiotic ( topical mupirocin 2 % ointment twice per day ) topical beta-blocker ( Timolol 0.5 % Gel Forming Solution ) accord dose-escalation schedule . Subjects see clinic day 7 , day 14 , 1 month 2 month therapy 1 month therapy complete . Photographs safety efficacy measurement take visit assess response therapy .</detailed_description>
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Hemangioma , Capillary</mesh_term>
	<mesh_term>Port-Wine Stain</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Mupirocin</mesh_term>
	<criteria>Infants weigh 412kg Infants correct gestational age 44 week 8 month age Infant ulcerate hemangioma Informed consent Ulceration large 16cm2 Ulcerated hemangioma active bleed infection time enrollment Disease threaten hemangioma meeting criterion oral propranolol Previous treatment topical/oral corticosteroid propranolol Medical history congenital heart disease decrease cardiac output , stroke/cerebral vasculopathy , active reactive airway disease metabolic disorder History allergic reaction Mupirocin Timolol Currently take medication would interact betablockers</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>8 Months</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Hemangioma</keyword>
	<keyword>Infantile Hemangioma</keyword>
	<keyword>Ulcerated Hemangioma</keyword>
	<keyword>Timolol</keyword>
	<keyword>Beta blocker</keyword>
	<keyword>Vascular anomaly</keyword>
</DOC>